Sima Sadrai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sima Sadrai has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Ali Noorbala
Psychosomatic Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication Ali Ghezelsefloo
1 shared publicationArash Jafaripoor
1 shared publicationBehjat Sheikholeslami
Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran
1 shared publication- Faramarz Fallahi
Faramarz Fallahi is Cardiologist and Associate Professor, Medicine Faculty; Shahed University; Tehran Iran
1 shared publication - Fatemeh Alijaniha
Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- 23 March 2018
- Published by Taylor & Francis in International Journal of Pharmacokinetics
- Vol. 3 (2) , 61-68
Comparison of Pharmacokinetic Parameters of Mycophenolic Acid in Two Groups of Iranian Kidney Transplant Patients
Aim: Mycophenolate mofetil is widely used in organ transplantation to prevent acute rejection. Following oral administration, it is rapidly converted to mycophenolic acid (MPA). Effectiveness and the incidence of rejection is influenced by area under the concentration–time curve (AUC). Effect of time after transplantations on pharmacokinetic (PK) parameters is considered. Method: PK parameters of MPA was characterized in two different groups of Iranian kidney transplant patients. MPA plasma concentrations following oral administration of 1 g mycophenolate mofetil in a multiple dosage regimen were measured in 21 (group 1) and 31 (group 2) individuals. Group 1 for more than 3 months and group 2 had been transplanted for 9–10 days. Blood samples were taken before and at different time points following dose administration (0–12 h). Peak plasma concentration (Cmax), time to reach Cmax (Tmax), and AUC were calculated for each patient. Results: The first plasma peak was reached in the range of 0.6–2 and 0.3–2 h ...
- 23 March 2018
- Published by Taylor & Francis in International Journal of Pharmacokinetics
- Vol. 3 (2) , 61-68
Comparison of Pharmacokinetic Parameters of Mycophenolic Acid in Two Groups of Iranian Kidney Transplant Patients
Aim: Mycophenolate mofetil is widely used in organ transplantation to prevent acute rejection. Following oral administration, it is rapidly converted to mycophenolic acid (MPA). Effectiveness and the incidence of rejection is influenced by area under the concentration–time curve (AUC). Effect of time after transplantations on pharmacokinetic (PK) parameters is considered. Method: PK parameters of MPA was characterized in two different groups of Iranian kidney transplant patients. MPA plasma concentrations following oral administration of 1 g mycophenolate mofetil in a multiple dosage regimen were measured in 21 (group 1) and 31 (group 2) individuals. Group 1 for more than 3 months and group 2 had been transplanted for 9–10 days. Blood samples were taken before and at different time points following dose administration (0–12 h). Peak plasma concentration (Cmax), time to reach Cmax (Tmax), and AUC were calculated for each patient. Results: The first plasma peak was reached in the range of 0.6–2 and 0.3–2 h ...
- 1 January 2016
- Published by Springer Nature in Vegetos
- Vol. 29 (3) , 189
A Brief Comparative Effectiveness Research (CER) about Conventional and Homeopathic Treatment of Type 2 Diabetic Patients
IndianJournals.com - Gateway to access, disperse and preserve knowledge!
- 1 January 2016
- Published by Springer Nature in Vegetos
- Vol. 29 (3) , 189
A Brief Comparative Effectiveness Research (CER) about Conventional and Homeopathic Treatment of Type 2 Diabetic Patients
IndianJournals.com - Gateway to access, disperse and preserve knowledge!
- 1 April 2015
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 164, 378-384
Heart palpitation relief with Melissa officinalis leaf extract: Double blind, randomized, placebo controlled trial of efficacy and safety
- 1 April 2015
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 164, 378-384
Heart palpitation relief with Melissa officinalis leaf extract: Double blind, randomized, placebo controlled trial of efficacy and safety